Squarepoint’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,600
Closed -$903K 4657
2025
Q4
$903K Buy
+3,600
New +$956K ﹤0.01% 2709
2025
Q3
Sell
-1,800
Closed -$473K 4706
2025
Q2
$473K Buy
+1,800
New +$438K ﹤0.01% 3326
2023
Q4
Sell
-14,200
Closed -$2.85M 4268
2023
Q3
$2.85M Buy
+14,200
New +$3M 0.01% 1549
2023
Q1
Sell
-3,841
Closed -$777K 3526
2022
Q4
$777K Hold
3,841
﹤0.01% 2006
2022
Q3
$676K Buy
+3,841
New +$786K ﹤0.01% 2038

Other funds holding LH

Squarepoint's LH Position: Q1 2026 in Review

Squarepoint reduced its Labcorp (LH) stake by 31% in Q1 2026, selling an estimated $16.7M and leaving 140,165 shares worth $37.4M. The position accounts for 0.04% of the portfolio, ranked #427.

Squarepoint first reported a position in LH in Q2 2015 and has held it in 41 quarters since. The position peaked at $50.6M in Q4 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Squarepoint held 140,165 shares of Labcorp worth $37.4M as of Q1 2026.
  • Squarepoint sold 61,665 Labcorp shares in Q1 2026, an estimated $16.7M.
  • Labcorp made up 0.04% of Squarepoint's portfolio in Q1 2026, its #427 holding.
  • Squarepoint first reported a position in Labcorp in Q2 2015 and has held it in 41 quarters since.
  • Squarepoint's Labcorp position peaked at $50.6M in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.